On January 6-7, 2009 NIDA convened a two-day meeting to address the issue of Substance Abuse and Comorbidities Among Military Personnel and Their Families. There is growing concern that military personnel returning from Iraq and Afghanistan are experiencing a range of difficulties, including traumatic brain injury (TBI), post traumatic stress disorder (PTSD), depression, anxiety, and tobacco, alcohol and drug abuse. The goals of the meeting were to gain an understanding of the intervention needs of military personnel, veterans, and their families regarding substance abuse and associated difficulties; discuss current prevention and treatment approaches being used with these populations; review existing drug abuse prevention and treatment interventions that may be appropriate for adapting and testing for use with these audiences; understand how to successfully conduct research in military and veteran settings; and formulate a research agenda for conducting addiction prevention. The meeting was organized in collaboration with the U.S. Army Medical Research and Materiel Command, the Department of Defense Health Affairs, the Army Center for Substance Abuse Programs, the Department of Veterans Affairs, the National Institute of Mental Health (NIMH), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Heart, Lung, and Blood Institute (NHLBI), and the National Cancer Institute (NCI). As a result of the discussions held, a series of recommendations for new research directions and priorities will be produced.
A meeting to report on the progress of, and plan the next steps for, the Centers of Excellence for Physician Information (CoE) program was organized by Elisabeth Davis, OSPC and held on February 5, 2009. The purpose of the NIDA CoEs, established in 2007, is to advance addiction awareness, prevention, and treatment in primary care practices by educating medical students, residents, and faculty on drug abuse and addiction in patient populations. The meeting debuted findings from a formative assessment measuring medical student and resident physician attitudes, beliefs, and behaviors on screening and treatment of substance abusing patients. It also evaluated how students prefer to obtain their information and the sources they use to learn more about drug abuse and addiction subject matters. The meeting also introduced the 11 curriculum resources developed by the CoEs as well as the findings from an extensive review of these resources. For the second half of the meeting, participants brainstormed on the next steps for the implementation and dissemination of CoE curriculum resources, and dissemination plans are underway. The meeting was attended by representatives from each of the four Centers which are located at medical schools in North Dakota at the University of North Dakota; Nebraska at Creighton University; Pennsylvania, at the University of Pennsylvania and Drexel University; and a consortium of four schools in Massachusetts — including the University of Massachusetts, Boston University, Tufts University, and Harvard University. Also in attendance were representatives from the American Medical Association and JBS, International.
NIDA's Office of Science Policy and Communications successfully hosted its first roundtable discussion for college journalism and communication majors, entitled Covering Addiction: A Roundtable for College Journalists on February 27, 2009. Fifteen students from universities around Washington D.C. participated in two question-and-answer sessions with NIDA scientists and some of the nation's top health journalists. The first topic of discussion, The Dope on Campus Drug Use, was led by NIDA Deputy Director Dr. Timothy P. Condon: Dr. Ruben Baler, Health Scientist Administrator, OSPC, Dr. Amelia Arria of the University of Maryland in College Park, and Dr. Carol J. Boyd of the University of Michigan also participated. The second topic, Reporting on the College High, included respectable journalists such as Lisa Stark of ABC News, Lauran Neergaard of Associated Press, and Jacqueline Duda, a freelancer who contributes to The Washington Post. The second panel also included John Burklow of the NIH Office of Communications. The roundtable received positive feedback from the students, and OSPC is considering more roundtables in the other parts of the country.
Dr. Yu (Woody) Lin, DCNBR, organized a meeting on Healthier Life Choices and Wellness through Tai-Chi/Qi-Gong Exercise: Implications for Substance Abuse which was held on May 6, 2009 at NIDA. The meeting was sponsored jointly by the Division of Clinical Neuroscience and Behavioral Research (DCNBR) and the Center for the Clinical Trials Network (CCTN). A major purpose was to introduce Tai-Chi/Qi-Gong exercise as a milder challenge and resource-free practice for physical and mental wellness, review its association to self-awareness, self-efficacy and attention/focus, and discuss its implications for stress release/tranquility, sleep disorder and substance abuse.
Dr. Yu (Woody) Lin of DCNBR, chaired a meeting on HIV & Substance Abuse: from Genes to Therapy that was jointly sponsored by the Department of Psychiatry, John A. Burns School of Medicine, University of Hawaii, National Institute on Drug Abuse (NIDA) Special Populations Office and the International Office and National Institute of Mental Health (NIMH). It was held on May 11-12, 2009 in Honolulu, Hawaii. The meeting was a session of the 2009 Hawaii Addictions Conference / AAPI Work Group Scientific Conference entitled Addiction and Related-Issues: Focusing on Recent Research and Culturally Relevant Treatments among Asian Americans and Pacific Islanders. It was organized jointly by the planning committees of the 10th Hawaii Addictions Conference and the 2nd National Institute of Health Asian Americans and Pacific Islanders Scientific Conference. The purpose of this conference was to: 1) identify findings from addiction research and science which translate to treatment modalities that improve clinical outcomes; and 2) integrate knowledge of Asian and Pacific Islanders cultural, psycho-social, and co-morbid characteristics into addiction research and treatment alternatives for special populations of those who are chemically dependent.
Drs. Bethany G. Deeds and Yonette F. Thomas, DESPR, convened a meeting of NIDA grantees to discuss their findings on "After Hurricane Katrina: Alcohol and Drug Abuse Research." The meeting was held on October 29, 2008 in Rockville, MD. Participants described their research findings on drug abuse and related risk behaviors among persons living in New Orleans and nearby areas most affected by the hurricane.
On February 23, 2009, Dr. Aria Crump, PRB, DESPR and Dr. Jeffrey Schulden, ERB, DESPR organized a joint NIDA/NIDCR meeting entitled "Opioid Prescribing to Adolescents in Dental Settings." This roundtable meeting with a small group of invited researchers and clinicians was held to discuss a potential research agenda around the prescribing of opioid analgesics to adolescents in dental settings. In the spirit of understanding patient and clinician perceptions and behaviors related to the prevention of opioid misuse and abuse among adolescents, the agenda included topical presentations by participants, discussant remarks, and moderated group discussion. Presenters discussed 1) current research on standard practices for dentists for prescribing opioid analgesics, 2) dentists' perceptions of the risk and safety of opioid analgesics, 3) current knowledge regarding opioid misuse and abuse among adolescents, and 4) the potential for prevention practices to decrease opioid misuse and diversion among adolescents.
On February 2-3, 2009, NIDA convened the second meeting of the Prevention Research Review Work Group in Bethesda, Maryland. This meeting was chaired by Dr. Mark Greenberg, who served as a recent member of the National Advisory Council on Drug Abuse and was coordinated by Dr. Denise Pintello. The purpose for this Work Group is to conduct a comprehensive review of NIDA's prevention research portfolio and to provide recommendations to effectively address the future direction of prevention research at NIDA. The Work Group members will prepare a written report for the National Advisory Council on Drug Abuse in May of 2009.
The annual DPMCDA P50 Medications Development Centers Meeting was held on March 30 and 31, 2009, in San Francisco, CA.
The National CTN Steering Committee Meetings were held March 24-26, 2009 in Rockville, MD. The following meetings/committees convened:
CTP and PI Caucuses
TEAM Task Force
Young Adult BUP Treatment
Research Utilization Committee
Research Development Committee
Node Coordinator Workgroup
Pharmacotherapy Special Interest Group
Health Services Research Interest Group
CTN 0030 POATS Long-term Follow-up Team
CTN 0031 STAGE-12 Study Team
Two workshops were held during the CTN Steering Committee Meetings:
Practical Approaches for Valid Subgroup Analysis in the CTN
The purpose of this workshop was to facilitate valid analyses of ethnic/racial minorities, gender and other subpopulations in the CTN. Speakers presented and discussed issues and strategies for planning and executing subgroup analyses during study design and data analysis, as well as when combining data sets from multiple studies.
Research Utilization in the CTN: Methods for Disseminating Evidence-based Treatments from the Frontlines of Community Treatment Programs
This workshop highlighted different methods CTPs have used to disseminate evidence-based treatment into their practice settings. Representatives from CTPs presented five dissemination methods that have resulted in successful implementation of evidence-based treatment. These methods included: 1) strategies to adapt treatments to best fit clinical practice; 2) use of opinion leaders; 3) quality improvement initiatives; 4) organizational change efforts; and 5) beyond journals: the use of popular professional magazines. In addition, there was a live demonstration of the CTN Dissemination Library website showing how this resource could support the adoption of evidence-based treatment. Workshop participants learned about approaches they might use to promote similar practices within their programs.
Dr. Timothy P. Condon, Deputy Director, NIDA, moderated "Addressing Substance Abuse and Comorbidities Among Military, Veterans and their Families: A Research Agenda" in Bethesda, Maryland on January 6, 2009.
Dr. Timothy P. Condon presented "Research on Addiction: What Have We Learned?" at the New York Society of Addiction Medicine (NYSAM) 5th Annual Medical Scientific Conference in New York, New York on January 24, 2009.
Dr. Timothy P. Condon presented "National Institute on Drug Abuse: Progress, Priorities & Plans for the Future" at the Community Anti-Drug Coalitions of America (CADCA) 19th National Leadership Forum in National Harbor, Maryland on February 11, 2009.
Dr. Timothy P. Condon presented "What Research Tells Us About Treatment" at Neurobiologia de l'addiccio in Barcelona, Spain on February 19, 2009.
Dr. Timothy P. Condon presented "Understanding Drug Abuse & Addiction Through Research" at the Roundtable for College Journalists in Bethesda, Maryland on February 27, 2009.
Dr. Timothy P. Condon presented "It's a Brain Disease: Beyond a Reasonable Doubt - The Neuroscience of Addiction" at the Supreme Court of Ohio Judicial College, Addictions: What Every Judge Should Know in Cincinnati, Ohio on March 5, 2009.
Dr. Timothy P. Condon presented "National Institute on Drug Abuse: Progress, Priorities & Plans for the Future" at the 2009 Annual Meeting of the Academic Consortium, in Washington, D.C. on March 12, 2009.
Dr. Timothy P. Condon spoke at National Inhalant Prevention Coalition Inhalants Press Briefing at the National Press Club, Washington, DC, March 16, 2009.
Dr. Cindy Miner, Deputy Director, OSPC participated in a pre-conference session entitled "Social Work Research Career Development at the National Institutes of Health" at the Society for Social Work and Research Conference on January 15, 2009, in New Orleans, LA.
Dr. Cindy Miner, Dr. Gaya Dowling, OSPC, and Ms. Carol Krause, OSPC Co-Presented a workshop entitled "The Real Inside Scoop on What Teens Want to Know About Drug Abuse" at CADCA's 19th Annual Leadership Forum on February 12, 2009, in Baltimore, MD.
Dr. Cindy Miner presented "Accessing Information on Addiction: An Update on NIDA's Research Dissemination Efforts" at the NIMH Outreach Partnership Program on March 18, 2009, in Charlotte, NC.
Dr. Ruben Baler, OSPC, presented a Keynote address on the Science of Addiction, at the 2009 Wyoming Methamphetamine and Substance Abuse, on January 8, 2009, in Casper, WY.
Dr. Ruben Baler lectured on the Science of Addiction for the George Washington University's Drug Awareness Freshman Course, on February 10, 2009, in Washington, DC.
Dr. Ruben Baler delivered a brief presentation on Brain Development and Decision making at the First NIDA's College Journalists Roundtable, on February 27, 2009, at the Natcher Conference Center, NIH campus, Bethesda, MD.
Dr. Ruben Baler presented a lecture entitled: "Navigating Around the Dangers of Abuse and Addiction" to the Youth National Leadership Forum at the CADCA Conference, on February 11, 2009, in Washington, DC.
Dr. Lula Beatty, Chief, Special Populations Office (SPO), chaired a session at a symposium titled "Addressing Social Justice through Health Research and Intervention" and made a presentation titled "Changing the Drug Abuse Research Agenda to Benefit Racial/Ethnic Minority Populations" at the National Multicultural Conference and Summit, January 16, 2009 in New Orleans.
Dr. Lula Beatty attended the Third National Leadership Summit on Eliminating Racial and Ethnic Disparities in Health: A Blueprint for Change on February 25-27, 2009 in National Harbor, Maryland.
Dr. Lula Beatty attended a conference titled "Black Women Academics in the Ivory Tower" at Rutgers University on March 5-6, 2009 in New Brunswick, New Jersey.
Dr. Lula Beatty attended a meeting convened by the Office of Minority Health, HHS, to discuss interest in efforts to address marginalized males on March 19, 2009 in Washington, DC. She agreed to chair a research interest group on this topic.
Dr. Lula Beatty participated as a faculty member in the Leadership Institute for Women in Psychology sponsored by the Women's Office, American Psychological Association, March 19, 2009 in Washington, DC.
Ana Anders, SPO, attended the "NIH Summit: The Science of Eliminating Health Disparities," December 15-18, 2008, in National Harbor, MD. In addition, she served as a review team leader and session moderator.
Ana Anders participated at the National Hispanic Science Network Steering Committee meeting February 27-28, 2009 in Miami, Florida.
Dr. Teri Levitin, Director, OEA, helped organize a workshop on mentoring the next generation of researchers for the biennial meeting of the Society for Research on Child Development in Denver, Colorado, April 2-4, 2009. Her specific presentation was on training mechanisms and the NIH review process.
Dr. Jerry McLaughlin, OEA, provided invited talks/reviews for the NIH Biocomputing Interest Group (BCIG) and the Washington Evolution Society on Reis's "The Synaptic Self: How Our Brains Become Who We Are"; Norbert Weiner's "The Human Use of Human Beings", and Ernst Myer's "What Makes Biology Unique."
Dr. Jerry McLaughlin coordinated and presented a talk as an expert panel member for the Scientific Program and Review Interest Group (SPRIG) on a session entitled "Innovation in Peer Review", February 6, 2009.
Dr. Jerry McLaughlin participated in the Addiction Interest Group's group discussion at the Gerontology Society's annual meeting in Washington DC.
Dr. Meenaxi Hiremath, OEA, participated in a Mock review at the Special Populations Research Development Seminar Series workshop on April 23 2009, at the Bethesda Doubletree Hotel in Bethesda, Maryland.
On January 22, 2009, Dr. Betty Tai, Director, CCTN, presented an overview of the CTN and the resources it has available, to the awardees of the Hubert H. Humphrey Drug Abuse fellowships.
On February 10, 2009, Dr. Betty Tai presented "How the National Institute on Drug Abuse (NIDA) Initiatives Promote Understanding of Prescription Opiates" at an FDA sponsored meeting titled "FDA Regulatory Processes and Standards for Review and Approval of Opioid Analgesics: An Educational Primer."
Dr. Roger Sorensen, DBNBR, and Dr. Diane Lawrence, ARP, organized a colloquium titled: "Neurotoxicity or Neuroprotection: The Two Sides of Drug Abuse Action" that was held on March 7, 2009 in conjunction with the 40th Annual Meeting of the American Society for Neurochemistry (ASN) , Charleston, SC. The purpose of this colloquium was to disseminate current research findings on the biological mechanisms underlying neurotoxicity or neuroprotection produced by drugs of abuse, including the role of glia in these processes. The presenters were: M. Kerry O'Banion (University of Rochester Medical Center); Katherine Conant (Johns Hopkins University Medical Center); Jean-Christopher Rochet (Purdue University); and Stanley Thayer (University of Minnesota Medical School).
Dr. Cora Lee Wetherington, Coordinator, Women and Sex/Gender Differences Research Program and DBNBR, was an invited participant and represented NIDA at the NIH Office of Research on Women's Health (ORWH) strategic planning workshop held at Washington University, March 4-6, 2009. This workshop was the first of four regional scientific workshops to explore new dimension for the NIH women's health research agenda for the next decade. Dr. Wetherington was a member of the workgroup, "Brain and Psychiatric Disorders." The next regional workshop will be convened May 27-28, 2009 at the University of California, San Francisco. These workshops are open to the public and ORWH invites both oral and written testimony.
Drs. Cora Lee Wetherington and Samia Noursi, DBNBR, chaired a symposium, "Biobehavioral Mechanisms of Sex Differences in Nicotine Addiction: A Translational Perspective," at the joint meeting of the Society for Research on Nicotine and Tobacco (SRNT) and SRNT-Europe in Dublin, Ireland, April 27-30, 2009. Presenters were Sakire Pogun, Ph.D. (Ege University Center for Brain Research, Department of Physiology, Bornova, Izmir, Turkey), Ken Perkins, Ph.D. (University of Pittsburgh), Caryn Lerman, Ph.D. (University of Pennsylvania), Julie Staley, PhD. (Yale University School of Medicine), and Stephanie O'Malley Ph.D. (Yale University School of Medicine).
Dr. Samia Noursi, Deputy Coordinator, Women and Sex/Gender Differences Research Program, represented NIDA at the "National Partnership to End Interpersonal Violence across the Lifespan (NPEIV), held in January 13, 2009 in New Orleans, LA. NPEIV is an overarching group of organizations, agencies, coalitions, and groups that embraces a national, multi-disciplinary and multicultural commitment to violence prevention across the lifespan.
Dr. Allison Hoffman, DBNBR, organized a seminar entitled "FDA Tobacco Product Regulation: Regulatory History and Overview of Pending Legislation", presented by Mitch Zeller. This event was hosted by the NIH Tobacco and Nicotine Research Interest Group (TANRIG) on February 25, 2009.
Dr. Allison Hoffman organized a Cutting Edge seminar entitled "Nicotine and Neuropeptides", sponsored by the NIDA Neuroscience Consortium and held on March 10, 2009. Presenters were Drs. Jim Fadel and Glen Hanson.
Dr. Allison Hoffman organized a webinar entitled "Novel Tobacco Products", presented by Dorothy Hatsukami on April 7, 2009. This event was hosted by the NIDA Nicotine and Tobacco Interest Group.
Dr. Allison Hoffman was invited to serve on the Healthy People 2020 Tobacco Workgroup, organized by the Centers for Disease Control and Prevention.
Dr. John Satterlee, DBNBR, played a key role in organizing a Roadmap Epigenomics Program-sponsored symposium entitled "Emerging Evidence for Epigenomic Changes in Human Disease" held in Natcher Conference Center in Bethesda, MD on March 16-17, 2009. This meeting consisted of 23 speakers who presented their cutting edge research on the role of epigenomic changes in the broad array of diseases of interest to NIH. Scientific sessions included "Epigenomic Mapping in Normal and Diseased Cells", "Epigenetics, Environmental Exposures, and Contributions to Disease", "Epigenetics and Disease", "The Potential for Epigenetic Diagnosis and Therapy", and "Integrating Epigenomics with Genetic and Epidemiological Studies". There were 48 poster presentations and a total of 700 registered attendees. Dr. Satterlee gave a presentation entitled: "The Roadmap Epigenomics Program: Why and How?"
Dr. John Satterlee presented an update on "The Roadmap Epigenomics Program" to the trans-NIH Genomics Workgroup on February 2, 2009.
Dr. Da-Yu Wu, DBNBR, represented NIDA at the NIH Neuroscience Blueprint workgroup for non-invasive human brain imaging for dynamics of neurotransmission and brain connectome. The imaging for dynamics of neurotransmission is now a Blueprint NIH Grand Challenge Grant Topic in both the Omnibus NIH RFA, jointly sponsored by NIDA. The Connectome project has been adopted as a Blueprint Grand Challenge beginning in FY10. Da-Yu Wu will work with the project team for this initiative.
Dr. Jonathan Pollock, DBNBR, has organized a weekly webinar series entitled, "Genetics of Nicotine Addiction and Lung Cancer." The purpose of this meeting is to foster collaboration of investigators studying smoking and smoking related phenotypes in the hopes that a meta-analysis can be conducted.
Drs. Diane Lawrence and David Shurtleff, DBNBR, presented a symposium entitled " HIV/AIDS and International Research Opportunities at the National Institute on Drug Abuse, National Institutes of Health" at Hong Kong University, Hong Kong, P.R. China, on April 17, 2009.
Drs. Diane Lawrence and David Shurtleff presented at a symposium entitled "Research and Funding opportunities at NIDA" at the 15th annual meeting of the Society for Neuroimmune Pharmacology, Wuhan, P.R. China on April 23, 2009.
Dr. Joseph Frascella, Director, DCNBR, gave two presentations at Hamilton College on the neurobiology of addiction and on the common neurobiological mechanisms between drug addiction and obesity in Clinton, NY, April 21-22, 2009. He also spoke with faculty and grants office staff on funding opportunities in the ARRA era.
Dr. Joseph Frascella attended the 2009 Summit on Food Addiction that discussed the latest scientific evidence for "food addiction" and its connection to the worldwide obesity epidemic. The Summit was held in Bainbridge Island, Washington, April 24 - 26, 2009.
Dr. Steven Grant, DCNBR, served on the organizing committee and co-chaired the session of "Addiction and Mental Health Disorders" during the Brain Blueprint Workshop on Harnessing Brain Plasticity for Human Applications held in Rockville, MD on April 21-22, 2009.
Dr. Steven Grant gave a presentation entitled "Advances in the Neuronal Basis of Addiction" for Grand Rounds at the Department of Psychiatry, University of California, Davis on March 20, 2009.
Dr. Steven Grant conducted a "Grant Writing Workshop" at the annual meeting of the Cognitive Neuroscience Society in San Francisco on March 23, 2009.
Dr. James M. Bjork, DCNBR, gave a lecture: "Rewards, Risk, and the Teenage Brain:
Insights from brain imaging research conducted at the NIH Clinical Center" at Natcher Auditorium at the NIH main campus on March 30, 2009.
Dr. James Bjork is participating in the Common Data Elements (CDE) workgroup for establishing recommended measures for substance abuse surveillance and assessment among veterans. The CDE initiative was organized by the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (Department of Defense).
Dr. Cecelia Spitznas and Dr. Lisa Onken, DCNBR, participated in launch of NIDA MED SBIRT website and Principles of Treatment 2nd Edition at the Washington Press Club on April 20, 2009.
Dr. Nicolette Borek, DCNBR, presented a grant-writing workshop at the Pediatric Academic Societies Southern Regional Meeting, February 12, 2009 in New Orleans.
Drs. Nicolette Borek and Karen Sirocco, DCNBR, organized and presented talks at the workshop "Grants 201 for Mid-Career and Senior Level Scientists: Supporting Thyself and Mentoring the Next Generation of Researchers" at the 2009 Society for Research on Child Development Biennial Meeting, April 1-4, 2009 in Denver, CO. Drs. Kathy Etz, Teresa Levitin, and Belinda Sims from NIDA and colleagues from NIMH and NICHD also participated in the session. Dr. Borek also presented a talk on consulting with NIH program staff at the session "NIH Transdisciplinary & Translational Research Priorities in Drug Abuse and Mental Health."
Dr. Shoshana Kahana, DCNBR, served as the Discussant on an Invited Panel discussion, "Contingency Management Strategies for Improving HIV Treatment Adherence", at the 4th International Conference on HIV Treatment Adherence, April 5-7, 2009, at the InterContinental Miami, sponsored by the International Association of Physicians in AIDS Care and the National Institute of Mental Health (NIMH).
Dr. Shoshana Kahana, DCNBR, moderated a panel discussion "Alcohol and Drug Use: Adherence Implications" at the 4th International Conference on HIV Treatment Adherence, April 5-7, 2009, at the InterContinental Miami, sponsored by the International Association of Physicians in AIDS Care and the National Institute of Mental Health (NIMH).
Dr. Wilson M. Compton, Director, DESPR, participated in meetings of the DSM-V Task Force and the Substance Use Disorders Workgroup, Arlington, Virginia, February 24 and March 24-25, 2009.
Dr. Wilson M. Compton chaired a plenary session on dimensional approaches to psychiatric diagnosis at the American Psychopathological Association (APPA) meeting New York, New York, March 5, 2009.
Dr. Wilson Compton participated in a webcast by the Substance Abuse Mental Health Services Administration (SAMHSA) to support National Alcohol and Drug Addiction Recovery Month. The webcast, entitled "Treatment 101 — Recovery Today," available on April 1 on SAMHSA's website at www.recoverymonth.gov. Other panelists included Dr. H. Westley Clark, Director of the Center for Substance Abuse at SAMHSA and Dr. Mark Willenbring, M.D., Director of Treatment and Recovery Research at NIAAA.
Dr. Wilson M. Compton presented a keynote address to the Federal District Court Reentry Conference, Portland, Oregon, April 2, 2009.
On February 9-10, 2009, Drs. Aleta Meyer, Aria Crump, and Belinda Sims, DESPR participated in the Federal Meeting on Prevention of Violence in Educational Settings. This meeting was convened by the National Institute of Justice and brought together federal partners from multiple agencies and institutes (i.e., CDC; SAMHSA; Office of Juvenile Justice and Delinquency; Federal Bureau of Investigation; Alcohol, Tobacco, and Fire Arms; Bureau of Justice Statistics; NIMH; NICHD; NIDA). The purpose of the meeting was to provide an update on current research related to violence prevention in educational settings, as well as to discuss ways to collaborate on activities to fill gaps in programming, data collection, research/evaluation, and communication toward the goal of violence prevention. Dr. Meyer highlighted NIDA-funded prevention and prevention services research portfolio with a presentation titled "Guiding Principles for Substance Use Prevention that Link to School-Based Violence Prevention."
Drs. Aleta Meyer, Augusto Diana, and Marsha Lopez, DESPR, presented at the "Physical Activity as Intervention" Scholar-in-Residence Workshop for the Southeast Connecticut Child and Family Agency on March 9, 2009, in Hartford, CT. Dr. Lopez's presentation was titled "Physical Activity and its Association with Depression, Obesity, and Drug Use across the Lifespan." Dr. Diana presented "Physical Activity as Drug Use Prevention and Treatment" with Dr. Dorothy Pekmezi of Brown University; he also led a break-out session titled "What Types and Characteristics of Activities Provide Benefits, and How?" Dr. Meyer served as a primary organizer for the day, providing opening and closing comments, as well as leading a break-out session titled "Physical Activity as a Strategy to Prevent Problem Behavior and Promote Positive Youth Development."
Dr. Marsha Lopez organized a field visit to NIDA's DESPR for predoctoral and postdoctoral trainees participating in the Johns Hopkins Drug Epidemiology T32 on November 4, 2008. The visit provided an opportunity for the T32 trainees to meet individually with DESPR Program Officials about their research interests and career goals, and to identify grant application mechanisms that might be most appropriate for them.
On March 18 and 19, 2009, Dr. Aleta Meyer gave two presentations at the 5th Annual Research and Evaluation of Adventure Programs Symposium in Atlanta, GA. Dr. Meyer gave the opening plenary, titled "Experiential Education and Public Health: The Potential to MOVE America Toward Health," as well as led a workshop titled "Seeking Funding Through a Small Business Approach."
On April 1, 2009 Dr. Belinda Sims and Dr. Molly Oliveri of NIMH Co-chaired a Preconference session at the Society for Research in Child Development meeting in Denver, CO titled "NIH Transdisciplinary and Translational Research Priorities in Drug Abuse and Mental Health." The purpose of this panel, co-sponsored by the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), was twofold: (1) to highlight funding priorities, strategic plans, and new initiatives; and (2) to discuss framing innovative translational research within NIH funding priorities. Panelists included Drs. Elizabeth Ginexi, PRB, DESPR, Allan Reiss of Stanford University, Philip Fisher of the Oregon Social Learning Center, and Nicolette Borek, DCNBR.
On April 3, 2009 Dr. Aria Crump presented on the NIH budget, major initiatives, & the public access policy as a part of a panel entitled "NIH Update on Policy Issues, Scientific Review, and Research Priorities" at the Society for Research in Child Development meeting in Denver, CO. The panel was organized by Dr. LeShawndra Price, ERB, DESPR.
Dr. Elizabeth Ginexi, DESPR, served as the Discussant for a Paper Symposium at the biannual meeting for the Society for Research in Child Development in Denver, CO on April 3, 2009 titled "Impact of Adverse Experiences in Childhood and Adolescence on Brain Development and Functioning: Results From Neuroimaging Studies." Drs. Jacqueline Bruce of the Oregon Social Learning Center, Deborah Yurgelun-Todd of Harvard Medical School, and Dr. Martin Teacher of McLean Hospital, Harvard Medical School presented papers.
Dr. Elizabeth Ginexi served as the Discussant for a Paper Symposium at the biannual meeting for the Society for Research in Child Development in Denver, CO on April 4, 2009 titled "Sitting Still and Learning to Read: Inhibitory Control and School Readiness in At-Risk Populations." Drs. Megan McClelland of Oregon State University, Erika Lunkenheimer of the University of Oregon, and Katherine Pears of the Oregon Social Learning Center presented papers.
Dr. Dionne Jones, DESPR, presented "NIDA Initiatives, Collaborations and Research Activities relating to Substance Abuse and HIV/AIDS" at the SAMHSA/CSAT Annual TCE/HIV and HIV Outreach Grantee Meeting: Maintaining Treatment Excellence, February 19, 2009.
Dr. Dionne Jones presented "Tips on Granstmanship for Early Career Investigators" at a NIDA-sponsored meeting "Integrating Services, Integrating Research for Co-occurring Conditions: A need for New Views and Action, Bethesda, MD, March 2, 2009.
Dr. Ivan Montoya, DPMCDA, presented a lecture entitled "Treatment of Drug Abuse in the Criminal Justice System" at the Latin American Conference of Therapeutic Justice and Drug Courts in San Juan, Puerto Rico, on April 17, 2009.
The 30th Annual Meeting of the Society for Clinical Trials took place May 3-6, 2009, in Atlanta, GA. CCTN staff participated in the following sessions: 1) Dr. Paul Wakim organized and will chair an invited session titled, "Is a Null Result a Failure? Can Anything Good Come out of Null Results?." The three invited speakers were Drs. Gail Neely (Washington University School of Medicine), Maria Mori Brooks (University of Pittsburgh Graduate School of Public Health) and Lawrence M. Friedman (NIH Consultant). 2) Joint work by Ms. Carmen Rosa and Dr. Paul Wakim on "Participation in Substance Abuse Clinical Trials: Comparing Gender and Racial/Ethnic Groups" was presented as part of a Contributed Paper Session titled, "Patient Recruitment, Enrollment and Retention".
Dr. Amy Newman, IRP, was invited to give a seminar at Duquesne University, School of Pharmacy, Pittsburgh, PA, entitled "Atypical Dopamine Uptake Inhibitors: A Strategy Toward Cocaine-Abuse Medication Discovery" in January 2009.
Dr. Amy Newman chaired a panel at the 42nd Annual Winter Conference on Brain Research entitled "Stop yawning and "see what's new at D2," in Copper Mountain, CO in January 2009.
Dr. Amy Newman participated in the 1st Behavior, Biology and Chemistry Translational Research in Addiction Meeting in San Antonio, TX and served on the Travel Award Committee and as a Poster/Oral Presentation Judge in February 2009.
Several IRP scientists presented at the Winter Conference on Brain Research, Copper Mountain, CO, January 24-31, 2009. Dr. Satoshi Ikemoto attended while Dr. Bruce Hope was chair of a panel entitled "Bighorn C1 Neuronal Ensembles in the Nucleus Accumbens."
Danielle Guez presented a poster entitled "Fluorescence Activated Cell Sorting: A Novel Method to Study Neurons Selectively Activated During Context-specific Cocaine Sensitization." Dr. Eisuke Koya presented a poster entitled "Daun02 Lesions Neuronal Ensembles that Encode Learned Associations between Cocaine and its Administration Environment." Sam Golden presented a poster entitled "Investigating the Role of Drug Administration Context in Haloperidol-Induced Striatal and Prefrontal Cortex Fos Expression after Repeated Haloperidol Injections."